CLINICAL_TRIALS
trial_result
· 2017-08-21
Clinical Trial Update: Immunomodulatory Properties of Ketamine in Sepsis [Phase 1, Phase 2]
Summary
This clinical trial update reports Phase 1/2 results on ketamine's immunomodulatory effects in patients with sepsis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Beth Israel Deaconess Medical Center | Conditions: Sepsis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-08-21